![](https://www.diabetesnews.com/wp-content/uploads/2014/03/rabies-cure-medicine-17066747-150x150.jpg)
What if glucagon could instead be as easily administered as insulin and utilized by people with diabetes to treat even mild lows? That’s the quest of Xeris, a company that is focusing on biologically friendly ways to make drug mixtures in liquid forms.